Executive Moves enGene appoints Amy Pott as chief global commercialization officer enGene Holdings (NASDAQ: ENGN) announced the appointment of Amy Pott as chief global commercialization officer—the company’s first dedicated executive for commercialization endeavors—reporting to Ron Cooper, CEO of... May 28, 2025